Several active research areas include: Metabolic dysfunction-associated steatotic liver disease (MASLD) : Multiple trials are evaluating semaglutide's effects on liver fat content and biomarkers, with preliminary data suggesting potential benefits in reducing hepatic steatosis and improving liver enzyme profiles Chronic kidney disease : Studies examining renal outcomes in patients with type 2 diabetes and established kidney disease, building on secondary analyses from SUSTAIN 6 showing reduced progression of diabetic nephropathy Obstructive sleep apnea : Ongoing trials investigating whether weight loss achieved with semaglutide improves sleep apnea severity and related cardiovascular outcomes Addiction and substance use disorders : Early-phase research exploring GLP-1 receptor agonists' potential effects on reward pathways and addictive behaviors, though this remains highly preliminary Alzheimer's disease and cognitive function : Preclinical evidence suggesting neuroprotective properties has prompted clinical trials examining cognitive outcomes in at-risk populations Researchers are also investigating combination therapies , such as cagrilintide plus semaglutide (CagriSema), which is currently under development
For those searching the web with Semaglutide making me throw up , its a sign that they need to make more gradual dietary adjustments
Users report that food thoughts decrease, cravings diminish, and the constant mental battle with eating largely disappears
Since then, its use has expanded into general anti-aging and metabolic medicine, where clinicians prescribe it off-label for visceral fat reduction, body composition improvement, and, more recently, cognitive support in older adults
It seems that semaglutide used for weight loss among patients with obesity does not meet typical cost-effectiveness standards
